124 related articles for article (PubMed ID: 33105921)
1. [Elimination of hepatitis C, our progress, challenges and hopes].
Rao HY; Li MY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):809-811. PubMed ID: 33105921
[TBL] [Abstract][Full Text] [Related]
2. [Hepatitis C elimination among drug users in China: challenges, strategies and experiences].
Wu T; Lin F; Wang J; Li H; Liu M; Zhang YR; Wang WW; Huang F
Zhonghua Gan Zang Bing Za Zhi; 2022 Sep; 30(9):1002-1006. PubMed ID: 36299198
[TBL] [Abstract][Full Text] [Related]
3. Interpretation of the National Action Plan for Eliminating Hepatitis C as a Public Health Threat (2021-2030).
Li J; Pang L; Liu Z
China CDC Wkly; 2022 Jul; 4(29):627-630. PubMed ID: 35919827
[TBL] [Abstract][Full Text] [Related]
4. Eliminate Hepatitis C as a Public Health Threat: A Narrative Review of Strategies, Gaps, and Opportunities for China.
Song Y; Li Y; Cheng H; Du X; Mi J; Le LV; Chen Z; Chan P; Sun J
Infect Dis Ther; 2022 Aug; 11(4):1427-1442. PubMed ID: 35821355
[TBL] [Abstract][Full Text] [Related]
5. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
[TBL] [Abstract][Full Text] [Related]
6. China's efforts to shed its title of "Leader in liver disease".
Li X; Xu WF
Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
[TBL] [Abstract][Full Text] [Related]
7. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
[TBL] [Abstract][Full Text] [Related]
8. Australia needs to increase testing to achieve hepatitis C elimination.
Scott N; Sacks-Davis R; Wade AJ; Stoove M; Pedrana A; Doyle JS; Thompson AJ; Wilson DP; Hellard ME
Med J Aust; 2020 May; 212(8):365-370. PubMed ID: 32167586
[TBL] [Abstract][Full Text] [Related]
9. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection in China: an emerging public health issue.
Qin Q; Smith MK; Wang L; Su Y; Wang L; Guo W; Wang L; Cui Y; Wang N
J Viral Hepat; 2015 Mar; 22(3):238-44. PubMed ID: 25131856
[TBL] [Abstract][Full Text] [Related]
11. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
12. Countdown to 2030: eliminating hepatitis B disease, China.
Liu J; Liang W; Jing W; Liu M
Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
[TBL] [Abstract][Full Text] [Related]
13. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
14. [Progress, challenges and countermeasures of global hepatitis C elimination].
Chen ZD
Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):812-816. PubMed ID: 33105922
[TBL] [Abstract][Full Text] [Related]
15. Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China.
Chen S; Mao W; Guo L; Zhang J; Tang S
BMJ Glob Health; 2020 Jun; 5(6):. PubMed ID: 32605935
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
European Union HCV Collaborators
Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
[TBL] [Abstract][Full Text] [Related]
17. Ecology, economics and political will: the vicissitudes of malaria strategies in Asia.
Kidson C; Indaratna K
Parassitologia; 1998 Jun; 40(1-2):39-46. PubMed ID: 9653730
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan.
Chhatwal J; Chen Q; Wang X; Ayer T; Zhuo Y; Janjua NZ; Kanwal F
JAMA Netw Open; 2019 May; 2(5):e193613. PubMed ID: 31074817
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
